ETFs Cipla Limited

CIPLA

INE059A01026

Name	YTD change	Weight	AuM
VANGUARD FTSE ALL-WORLD UCITS ETF - USD	+12.39%	-	27,154 M€
DIMENSIONAL WORLD EQUITY ETF - USD	+13.58%	-	1,674 M€
UNLIMITED HFND MULTI-STRATEGY RETURN TRACKER ETF - USD	+6.30%	-	37 M€
CI GROWTH ASSET ALLOCATION ETF -CAD	+11.24%	-	67 M€
DIMENSIONAL EMERGING MARKETS CORE EQUITY 2 ETF - USD	+19.91%	-	9,273 M€
FIRST TRUST INDIA NIFTY 50 EQUAL WEIGHT ETF - USD	-14.58%	2.13%	118 M€
BMO MSCI INDIA SELECTION EQUITY INDEX ETF - CAD	-18.76%	1.26%	125 M€
ISHARES MSCI INDIA INDEX	-16.65%	1.12%	48 M€
GLOBAL X INDIA NIFTY 50 ETF - AUD	-21.48%	0.76%	124 M€
HSBC MSCI EMERGING MARKETS VALUE ESG UCITS ETF - USD	+22.44%	0.75%	122 M€
WISDOMTREE INDIA HEDGED EQUITY FUND - USD	-13.23%	0.72%	6 M€
UBS MSCI EM EX CHINA SOCIALLY RESPONSIBLE UCITS ETF - USD	+52.66%	0.72%	18 M€
ISHARES INDIA INDEX ETF - CAD	-14.54%	0.71%	96 M€
ISHARES MSCI INDIA UCITS ETF ACCUMULATING - USD	-14.55%	0.69%	5,254 M€
UBS MSCI INDIA UNIVERSAL UCITS ETF - USD	-12.87%	0.68%	2 M€
INVESCO INDIA ETF - USD	-24.56%	0.66%	108 M€
ISHARES INDIA 50 ETF - USD	-17.51%	0.66%	565 M€
ISHARES MSCI INDIA ETF - USD	-14.26%	0.55%	6,661 M€
ISHARES EDGE MSCI MIN VOL EMERGING MARKETS INDEX ETF - CAD	+19.94%	0.54%	86 M€
ISHARES MSCI EMERGING MARKETS MIN VOL FACTOR ETF - USD	+15.14%	0.53%	3,601 M€
ISHARES EDGE MSCI EM MINIMUM VOLATILITY UCITS ETF - USD	+19.09%	0.52%	491 M€
JPM INDIA RESEARCH ENHANCED INDEX EQUITY ACTIVE UCITS ETF ACC - USD	-10.57%	0.51%	99 M€
BMO LOW VOLATILITY EMERGING MARKETS EQUITY ETF - DISTRIBUTING - CAD	+32.66%	0.49%	68 M€
FRANKLIN FTSE INDIA UCITS ETF - ACC - USD	-9.18%	0.47%	2,189 M€
FRANKLIN FTSE INDIA ETF DIST - USD	-13.88%	0.46%	2,692 M€
WISDOMTREE EMERGING MARKETS QUALITY DIVIDEND GROWTH FUND - USD	+27.70%	0.45%	148 M€
LION-CHINA MERCHANTS EMERGING ASIA SELECT INDEX ETF - USD	-11.94%	0.45%	49 M€
WISDOMTREE INDIA EARNINGS FUND - USD	-13.21%	0.4%	2,054 M€
XTRACKERS NIFTY 500 INDIA ETF - USD	-13.72%	0.37%	5 M€
STATE STREET SPDR MSCI EMERGING MARKETS STRATEGICFACTORS ETF - USD	+21.64%	0.28%	60 M€
AMUNDI MSCI EMERGING MARKETS ESG SELECTION - UCITS ETF DR (C) - USD	+15.58%	0.27%	1,125 M€
WISDOMTREE EMERGING MARKETS MULTIFACTOR FUND ETF - USD	+19.60%	0.26%	180 M€
ISHARES ESG ADVANCED MSCI EM ETF - USD	+22.84%	0.25%	164 M€
XTRACKERS MSCI EMERGING MARKETS ESG UCITS ETF 1C - USD	+7.31%	0.25%	1,545 M€

Cipla specializes in development, manufacturing and marketing of pharmaceutical products. The group provides prescription products and OTC medicines for the treatment of cardiovascular, ophthalmic and dermatological diseases, respiratory troubles, cancers, allergies, infections etc. Besides, Cipla develops and sells veterinary products. Net sales by source of income break down between sale of products (96.9%) and services (3.1%). Net sales are distributed geographically as follows: India (39.4%), the United States (18.5%), South Africa (17%) and other (25.1%).

Employees

31,369

Sector

Pharmaceuticals

Calendar

10-27 Earnings release - Q2 2027

More about the company

Income Statement and Estimates

Projected Income Statement - Annual - Cipla Limited

More financial data

Market Closed - NSE India S.E. 15:05:07 12/10/2026 +04			5-day change	1st Jan Change
1,311.30 ^INR	+0.79%		-1.81%	-13.23%

10-06	Cipla Health Announces Appointment of Gaurav Kaul as Managing Director, Effective October 2026	CI
09-22	Cipla Limited and Cipla Usa Inc. Announces Management Changes, Effective October 1, 2026	CI

ETFs Cipla Limited

Stocks

CIPLA

INE059A01026

Pharmaceuticals

ETFs positioned on Cipla Limited

Company Profile

Income Statement and Estimates